Publication details
Nozokomiální pneumonie – antibiotická léčba
| Title in English | Nosocomial pneumonia - antibiotic treatment |
|---|---|
| Authors | |
| Year of publication | 2021 |
| MU Faculty or unit | |
| Web | http://kdp.uzis.cz/index.php?pg=kdp&id=25 |
| Description | Nosocomial pneumonia (HAP - Hospital Acquired Pneumonia and VAP - Ventilator Associated Pneumonia) is the second most common nosocomial infection and the most common in intensive care unit patients. In terms of morbidity, mortality and economic costs, HAP/VAP is the most important group of nosocomial infections; and the problem of bacterial resistance is often encountered in its treatment. Consistent prevention and proper antibiotherapy can reduce the incidence, increase the success rate of treatment and limit the increase in bacterial resistance, but nosocomial pneumonia cannot be completely eradicated. The importance of adequate antibiotic treatment, not underestimating the patient's condition, and not using broad-spectrum antibiotics where they are not necessary should be emphasised. Furthermore, it is important to seek early de-escalation of treatment and to reduce the duration of antibiotic administration. |